Anthony S. Fiorino's Net Worth

-$27.9 Thousand

Estimate Recalculated Jan 7, 2025 04:11PM EST

Who is Anthony S. Fiorino?

Anthony S. Fiorino does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NAVIDEA BIOPHARMACEUTICALS, INC., BRAINSTORM CELL THERAPEUTICS INC., and IMMUNE PHARMACEUTICALS INC.

SEC CIK

Anthony S. Fiorino's CIK is 0001608901

Past Insider Trading and Trends

2014 was Anthony S. Fiorino's most active year for acquiring shares with 8 total transactions. Anthony S. Fiorino's most active month to acquire stocks was the month of August. 2020 was Anthony S. Fiorino's most active year for disposing of shares, totalling 1 transactions. Anthony S. Fiorino's most active month to dispose stocks was the month of January. 2018 saw Anthony S. Fiorino paying a total of $18,877.50 for 75,000 shares, this is the most they've acquired in one year. In 2020 Anthony S. Fiorino cashed out on 75,000 shares for a total of $262.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Snapshot price: $0.0251

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Snapshot price: $0.2803

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.00%
500
$3.60
$1,797.70
2.5K
Oct 15
Form 4
+66.67%
800
$3.84
$3,072.00
2K
Sep 18
Form 4
∞
18K
$0.28
$5,125.50
18K
Sep 12 - Sep 15
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
No matching records found

IMMUNE PHARMACEUTICALS INC No price found

Chief Medical Officer and COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-75.00K
—
-$262.50
0
Feb 3
Form 4
+50.00%
25K
$0.24
$5,977.50
75K
May 22
Form 4
∞
50K
$0.26
$12,900.00
50K
May 17
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found